Prime Global, a recognised global leader in medical communications and market access, has strengthened its Evidence, Access, and Patient Practice with the acquisition of HCD Economics, an academically aligned organisation focusing on health economics and outcomes research (HEOR) and real-world evidence (RWE). HCD will work closely with Prime Global’s highly experienced medical communications agencies and specialist consultancies, including market access consultancy, Prime Access, and patient engagement experts, Prime Patient, to deliver integrated evidence-led services.read more >>
Prime Access is a specialist Market Access and HEOR consultancy, operating at group level. Partnering with the Prime Global agencies or consulting directly where needed, Prime Access can support you across the full range of payer evidence, HEOR publications, market access, value communication, and public policy.
How can Prime Access help?
Prime Access is driving excellence in payer communications. Our Market Access and HEOR team have first-hand experience in the daily decisions that payers have to make, as well as experience within the pharmaceutical industry as part of drug development teams. The synergy between this extensive experience and Prime Global’s 24-year heritage of generating brilliant medical communications creates powerful Market Access messaging to support your payer communications.
For pharmaceutical and biotechnology companies, we help shape the narrative, translating science into compelling value propositions that resonate with stakeholders across healthcare systems. For payers and policy makers, we empower the best value choices, providing a clear, coherent basis for decisions that can support the right access for patients. At Prime Access, our value proposition is clear; our solutions are designed by experience.
Market Access Services
Prime Access offers a range of services specialising in health economics, market access, and payer communications:
Payer evidence, including value dossiers and HTA local submissions, systematic reviews, and evidence generation planning and review.
HEOR publications, including HEOR medical congress support (such as abstracts and posters) and HEOR medical writing (such as manuscripts).
Market access and value communications, including landscape reviews; value message development; GVD and ACMP dossiers, slide decks, objection handlers, and training; HTA planning and payer engagement.
Public policy and the patient voice, including social listening; virtual meetings and workshops; public policy white papers and campaign rollouts; multi-faceted external and internal communication materials.
We recognise that market access communications can reach multiple stakeholders.
Communicating the full financial, societal and patient impacts of a disease to public policy makers is important to ensure effective treatments and care services are prioritised appropriately at the country level.
Engagement of patient association groups in market access communications ensures the patient voice is represented in the overall value story of a new product.
HTA submissions are increasingly leveraging the patient and caregiver perspective to supplement clinical data.
Engaging affiliates early in the product lifecycle can help shape the value story to ensure key messages are being communicated to suit country-specific needs.
By utilising our digital capabilities, we can prepare and engage multi-stakeholder audiences in the value story development.
A highly experienced team
The Prime Access team is led by Sue O’Leary, who has over 25 years’ payer experience supporting large pharma and biotech companies in global market access. With a background as a pharmacist, she has worked within the NHS as well as in-house with AstraZeneca before going into market access and HEOR consultancy.
She is supported by a multi-skilled worldwide team with a wide range of therapeutic area expertise.
Get in touch!
If you would like to find out more about how our Prime Access team can bring the right solutions to you, please contact Sue O’ Leary, Senior Vice President of Prime Access, on firstname.lastname@example.org.
Alternatively, email us on email@example.com or use the form on our Contact Us page.
Prime Access News.
Prime Global acquires HCD Economics, creating an innovative evidence-generating, HEOR, value & communications groupPrime Global 24 January, 2022
The Digital Payer: Fact or Fiction?Prime Global 21 October, 2021
Our experts, Sue O’Leary, Senior Vice President Prime Access, Jenny Blackham, Vice President Client Partnerships and Head of Digital Solutions Michelle Collins recently led a webinar with the team at NetworkPharma and MedComms Networking. Discussing ‘the digital payer – fact or fiction?’ the webinar was a brilliant platform to discuss perspectives and share ideas about about evolving payer communications in the changing digital landscape.read more >>
Overcoming the challenges of gene therapyPrime Global 15 September, 2021
Once considered science fiction, a number of different gene therapy approaches are now being adopted in clinical practice to target a range of diseases. Our Prime Omics team discuss ‘overcoming the challenges of gene therapy’ in their whitepaper. Read the full piece below.
read more >>